A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

Clinical trial NCT07112378 · RECRUITING

Trial details

NCT number: NCT07112378
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Esophagitis (EoE)

Start date: 2025-11-10
Primary completion: 2028-06-19
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.